ArticleObesity surgery2025
International Federation for Surgery for Obesity and Metabolic Disorders Position Statement on the role of Upper Gastrointestinal Endoscopy Before and After Metabolic Bariatric Surgery.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Conversion to One-Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass for Treatment of Gastroesophageal Reflux Disease after Sleeve Gastrectomy: A Systematic Review and Meta-analysis.Obesity surgery · 2026Pooled it
- Scoping Review of Reflux after Primary One Anastomosis Gastric Bypass: Navigating the Maze to Enhance the Evidence Base.Obesity surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe International Federation for Surgery for Obesity and Metabolic Diseases (IFSO) provides Position Statements to assist clinical decision making. The use of upper gastrointestinal endoscopy (UGIE) before and after MBS is a topic of debate in clinical practice. This Position Statement updates two previous Position Statements on this issue.
methodsA taskforce undertook a systematic review of available literature according to PRISMA guidelines. Critical appraisal of the methodology of each paper was performed according to the Joanna Briggs Institute. Recommendations based on the derived data were generated and then approved by the Scientific Committee of IFSO.
resultsThe rate of abnormal findings on pre-MBS UGIE was 61% (95% CI 55%-67%; I
conclusionsNoting the heterogenous nature of the data, high likelihood of bias, variability of definitions of UGIE detected pathology and Limited follow-up beyond 2 years, seven recommendations for clinical practice are provided, with a caveat that the data should be re-explored in 3 years.
Indexed as
Identifiers
41108366What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.